Background: Clinical genetic evaluation for patients with dilated cardiomyopathy (DCM) is minimally implemented and models of care are not defined. To understand current genetics care for DCM, a systematic needs assessment was conducted. Methods: Principal Investigators (PIs) of the DCM Consortium convened at the Summe...
E. Jordan, T. Moscarello, Hibatallah Khafagy et al.· Circulation: Heart Failure· 0 citations
Heart transplantation remains the definitive treatment for end-stage heart failure and contemporary immunosuppressive regimens, typically a calcineurin inhibitor, antiproliferative agent, and corticosteroids, are applied with minimal pre-emptive individualization, despite profound heterogeneity in recipient immune biol...
Marc D. Samsky, Maryjane Farr, Aditya Parikh et al.· Journal of Cardiac Failure· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.